SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
104 Celgene Corporation to Sell Chiral Intermediates Business To Cambrex CorporatioO-MY-O-11/18/1997
103 Single patient data is not warrant that thalidomide or SelCIDS may be drug of cMiljenko Zuanic-11/14/1997
102 [CONFERENCE] TNF-a ANTAGONISTS: MONOCLONAL ANTIBODIES, SOLUBLE RECEPTORS, THAMiljenko Zuanic-11/12/1997
101 Hi Peter, dbuki, and others: In May 1996 CELG announced article in Molecular Miljenko Zuanic-11/12/1997
100 Peter, Along the same lines, see my post #60 on this thread, quoting from Natudbuki-11/12/1997
99 Miljenko, A quick Medline search revealed _many_ reports of "novel" Biomaven-11/12/1997
98 Biao: Thanks for response. The selective cAMP PDE-4 inhibitor(s) , as TNF-aMiljenko Zuanic-11/11/1997
97 Jim: Thanks for remind me on Chiro/SP and their PDE-4 inhibitor. For those whoMiljenko Zuanic-11/11/1997
96 Hi, Miljenko, First, I don't know much about PDE-4 so I can only talk aboubiao luo-11/11/1997
95 Miljenko- Just to step in for a spot, as I understand it, quite a few PDE IV inJames Silverman-11/11/1997
94 Hi Biao: Welcome to thread. Thanks very much for clarification. You are very cMiljenko Zuanic-11/10/1997
93 Miljenko & biao: Thanks for the comments. I've been looking at the CNTBiomaven-11/10/1997
92 Just to clarify on the mechnism of IMNX drug. While CNTO's is a monoclonalbiao luo-11/10/1997
91 Peter: For last two years I am trying to develop understanding of the disease:Miljenko Zuanic-11/7/1997
90 Miljenko: SelCID Phase 1: "safe and well-tolerated" biz.yahoo.com Biomaven-11/7/1997
89 Thanks Peter. I will tried to figure (in coming several days, ARRS/SQNA and DMiljenko Zuanic-11/3/1997
88 Miljenko, Here is the quote from the S-3 that refers to Celgene as a supplier Biomaven-11/3/1997
87 Wow - glad to see others are starting to follow this bt. Yolanda - it looks liO-MY-O-10/29/1997
86 HI All: Nice to see that there are some people out there following this one. IPaul Vinarub-10/29/1997
85 Ed, Thanks for links. Yolanda, CELG is negotiating with FDA how (condition) toMiljenko Zuanic-10/28/1997
84 Ed, a rather surprising secondary? Hopefully we will see additional good news bdbuki-10/28/1997
83 Thanks for the update, Ed. I've been lurking here for a bit, and am curiouyolanda-10/28/1997
82 Celgene Corporation Reports Third Quarter Results biz.yahoo.com Celgene Posts O-MY-O-10/28/1997
81 Hi Ad, Peter! Ad: Thanks for two posts. News sound good. As I stated early, thMiljenko Zuanic-10/17/1997
80 Hi everybody: Well I bought some today at $12. I'm an old Sepracor fan, anBiomaven-10/17/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News